Abstracts

623 – Hypertension: A Major Factor in Low Verbal Fluency Among People Aged 50+ Living With HIV in Senegal

Background Decline in verbal fluency, observed both in aging and HIV infection, is associated with reduced quality of life. The association of cardiometabolic diseases with verbal fluency is well described in Western Countries, not in Sub-Saharan Africa, especially in older people living with HIV (PLWH). This study aims to identify the factors associated with verbal…

588 – Association of CSF Viral Compartmentalization and Macrophage Tropism With Neurosymptomatic HIV

Background HIV-1 can be detected in cerebrospinal fluid (CSF) throughout untreated infection but it is unknown how often this is due to local replication in the CNS. In people with HIV-associated dementia (HAD), local replication can generate genetically distinct viral populations in the CNS (compartmentalized) with the unique ability to efficiently infect myeloid lineage cells…

622 – Greater Cognitive Decline in Cognitively Unimpaired Older Thai PWH at Baseline

Background Cognitive impairment remains a crucial health issue among people with HIV (PWH). However, the course of cognitive impairment has shifted considerably since the introduction of combined antiretroviral therapy. We aimed to determine the differences in cognitive decline between PWH with and without cognitive impairment at baseline in a cohort of virologically suppressed older PWH. Methods Virologically…

630 – Neuroinflammation Associated With Levels of HIV DNA in the Frontal Cortex of Virally Suppressed PWH

Background Currently ~30% of people with HIV (PWH) who are virally suppressed with antiretroviral therapy (ART) develop a form of HIV-associated neurocognitive disorders. The presence of a viral reservoir (and associated neuroinflammation) in the brain and ongoing systemic inflammation penetrating the brain are thought to play crucial roles. However, the precise effects of viral mediated…

606 – Single-Nucleus Multiomics Reveals Dysfunction in Multiple Glial Cell Types in Brain Tissue of PWH

Background Central nervous system (CNS) dysfunction is a recognized complication in some people with HIV (PWH). As part of SCORCH (a large-scale, consortium-wide effort examining transcriptional and epigenetic alterations in the brains of PWH), we aim to identify key cell populations and pathways affected by HIV that may be targeted in therapies for HIV-associated CNS…

592 – Plasma Inflammation Is Associated With Brain Cellularity in Diffusion-Based Spectral Imaging in HIV

Background Elevated levels of inflammation and neurodegeneration in the brain and periphery are associated with worse brain health outcomes in persons without HIV (PWoH). People with HIV (PWH) may have greater peripheral inflammation and neurodegeneration that may cause elevated brain inflammation and white matter changes. Brain inflammation can be measured using diffusion-based spectral imaging (DBSI)…

633 – Plasma Neopterin as a Potential Biomarker for Neurocognitive Impairment in Aging People With HIV

Background Neopterin, a biomarker of immune activation, has been widely studied in cerebrospinal fluid as a correlate of neuroinflammation and neurocognitive impairment (NCI) in people with HIV (PWH). Recent evidence suggests that plasma neopterin could be useful in identifying PWH at risk of developing NCI. This study explores neopterin as a potential plasma biomarker for NCI using…